H. Andersson
发表
Malin Helmestam,
H. Andersson,
A. Stavreus-Evers,
2012
.
H. Andersson,
E. Brittebo,
2012,
Archives of Toxicology.
Doris A Taylor,
H. Andersson,
C. Hochman-Mendez,
2021,
Biomaterials science.
Mo1850 Obeticholic Acid (INT-747) Confers Disease Protection Against Clostridium difficile Infection
T. Savidge,
H. Andersson,
Joseph A. Sorg,
2015
.
H. Andersson,
E. Brittebo,
U. Garscha,
2011,
Toxicology.
P. Hwu,
Y. Lou,
H. Andersson,
2009
.
Malin Helmestam,
H. Andersson,
E. Brittebo,
2010,
Drug Metabolism and Disposition.
Stephen T. C. Wong,
H. Andersson,
R. Serda,
2012,
Molecular pharmaceutics.
H. Andersson,
M. Barry,
Rana A. K. Singh,
2003
.
C. Liu,
P. Hwu,
Y. Lou,
2009,
The Journal of Immunology.
H. Andersson,
S. Forman,
L. Cooper,
2012
.
H. Andersson,
S. Forman,
L. Cooper,
2011,
Blood.
P. Hwu,
J. Abbruzzese,
P. Cano,
2011,
Vaccine.
H. Andersson,
M. Barry,
Rana A. K. Singh,
2004,
Immunological reviews.
H. Andersson,
M. Barry,
2004,
Molecular therapy : the journal of the American Society of Gene Therapy.
H. Andersson,
M. Barry,
Rana A. K. Singh,
2006,
Molecular therapy : the journal of the American Society of Gene Therapy.
H. Andersson,
E. Brittebo,
Elena Piras,
2009,
Toxicology.
H. Andersson,
E. Brittebo,
2012,
Archives of Toxicology.
H. Andersson,
M. Barry,
M. Passeri,
2005,
Human gene therapy.
Zheng-zheng Shi,
H. Andersson,
R. Serda,
2014,
Vaccines.